Parkinson's Disease Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Parkinson's Disease stocks.

Parkinson's Disease Stocks Recent News

Date Stock Title
May 10 ANVS Amicus (FOLD) Q1 Earnings Top, Sales Lag, '24 Outlook Updated
May 10 ANVS Xenon (XENE) Q1 Earnings Beat Estimates, Pipeline in Focus
May 9 ANVS Annovis Bio to post late-stage data for Parkinson's drug in June
May 9 ANVS Catalyst (CPRX) Q1 Earnings Beat, Firdapse Sales Drive Revenues
May 9 ITCI Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Just Released Its First-Quarter Earnings: Here's What Analysts Think
May 9 ANVS Annovis Announces Unblinding of the Buntanetap Phase III Data in Parkinson’s Disease
May 9 PRTC PureTech Founded Entity Seaport Therapeutics Presents Data from Multiple SPT-300 Trials at Society of Biological Psychiatry (SOBP) Annual Meeting
May 9 DNLI Denali Therapeutics First Quarter 2024 Earnings: US$0.68 loss per share (vs US$0.80 loss in 1Q 2023)
May 9 ANVS Acadia (ACAD) Q1 Earnings Surpass Estimates, Revenues Miss
May 8 ITCI Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q1 2024 Earnings Call Transcript
May 8 ANVS Intra-Cellular (ITCI) Q1 Earnings and Sales Beat Estimates
May 8 ANVS Pacira (PCRX) Q1 Earnings Miss, Exparel Sales Drive Revenues
May 8 DNLI Denali (DNLI) Q1 Earnings Miss, Pipeline Progress in Focus
May 8 ITCI Intra-Cellular Therapies to Participate in Two Upcoming Investor Conferences
May 8 VYGR Voyager Therapeutics Presents Data for Second-Generation, TRACER™-Generated Capsids and CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting
May 8 ITCI Intra-Cellular Therapies Inc (ITCI) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue ...
May 7 DNLI Denali Therapeutics Q1 2024 Earnings: Misses Revenue Estimates Amid Strategic Shifts
May 7 DNLI Denali Therapeutics GAAP EPS of -$0.68 beats by $0.02
May 7 DNLI Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
May 7 ITCI Intra-Cellular Therapies, Inc. (ITCI) Q1 2024 Earnings Call Transcript
Parkinson's Disease

Parkinson's disease (PD) is a long-term degenerative disorder of the central nervous system that mainly affects the motor system. The symptoms generally come on slowly over time. Early in the disease, the most obvious are shaking, rigidity, slowness of movement, and difficulty with walking. Thinking and behavioral problems may also occur. Dementia becomes common in the advanced stages of the disease. Depression and anxiety are also common, occurring in more than a third of people with PD. Other symptoms include sensory, sleep, and emotional problems. The main motor symptoms are collectively called "parkinsonism", or a "parkinsonian syndrome".The cause of Parkinson's disease is generally unknown, but believed to involve both genetic and environmental factors. Those with a family member affected are more likely to get the disease themselves. There is also an increased risk in people exposed to certain pesticides and among those who have had prior head injuries, while there is a reduced risk in tobacco smokers and those who drink coffee or tea. The motor symptoms of the disease result from the death of cells in the substantia nigra, a region of the midbrain. This results in not enough dopamine in these areas. The reason for this cell death is poorly understood, but involves the build-up of proteins into Lewy bodies in the neurons. Diagnosis of typical cases is mainly based on symptoms, with tests such as neuroimaging being used to rule out other diseases.There is no cure for Parkinson's disease, with treatment directed at improving symptoms. Initial treatment is typically with the antiparkinson medication levodopa (L-DOPA), with dopamine agonists being used once levodopa becomes less effective. As the disease progresses and neurons continue to be lost, these medications become less effective while at the same time they produce a complication marked by involuntary writhing movements. Diet and some forms of rehabilitation have shown some effectiveness at improving symptoms. Surgery to place microelectrodes for deep brain stimulation has been used to reduce motor symptoms in severe cases where drugs are ineffective. Evidence for treatments for the non-movement-related symptoms of PD, such as sleep disturbances and emotional problems, is less strong.In 2015, PD affected 6.2 million people and resulted in about 117,400 deaths globally. Parkinson's disease typically occurs in people over the age of 60, of which about one percent are affected. Males are more often affected than females at a ratio of around 3:2. When it is seen in people before the age of 50, it is called young-onset PD. The average life expectancy following diagnosis is between 7 and 14 years. The disease is named after the English doctor James Parkinson, who published the first detailed description in An Essay on the Shaking Palsy, in 1817. Public awareness campaigns include World Parkinson's Day (on the birthday of James Parkinson, 11 April) and the use of a red tulip as the symbol of the disease. People with Parkinson's who have increased the public's awareness of the condition include actor Michael J. Fox, Olympic cyclist Davis Phinney, and late professional boxer Muhammad Ali.

Browse All Tags